Subject(s)
COVID-19/epidemiology , Pandemics , Primary Health Care , Public Health , Quarantine/trends , Humans , Primary Health Care/legislation & jurisprudence , Public Health/legislation & jurisprudence , Quarantine/legislation & jurisprudence , SARS-CoV-2 , State Medicine/legislation & jurisprudence , United KingdomSubject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Mandatory Programs/legislation & jurisprudence , State Medicine/legislation & jurisprudence , Vaccination/legislation & jurisprudence , COVID-19/economics , COVID-19/epidemiology , COVID-19 Vaccines/economics , England/epidemiology , Government Employees/legislation & jurisprudence , Health Policy/economics , Health Policy/legislation & jurisprudence , Humans , Mandatory Programs/economics , Mandatory Programs/standards , State Medicine/standards , Vaccination/economics , Vaccination/standardsSubject(s)
COVID-19/prevention & control , Health Personnel/legislation & jurisprudence , Mandatory Programs/legislation & jurisprudence , State Medicine/legislation & jurisprudence , Vaccination/legislation & jurisprudence , Attitude of Health Personnel , COVID-19/epidemiology , COVID-19/virology , England/epidemiology , Health Personnel/standards , Humans , Immunization, Secondary/standards , Infectious Disease Transmission, Professional-to-Patient/prevention & control , Mandatory Programs/standards , Pandemics/prevention & control , SARS-CoV-2/pathogenicity , State Medicine/standards , Vaccination/standardsSubject(s)
COVID-19/prevention & control , Health Policy/legislation & jurisprudence , State Medicine/organization & administration , COVID-19/epidemiology , COVID-19/transmission , Humans , Pandemics/prevention & control , Politics , Public Health/legislation & jurisprudence , State Medicine/legislation & jurisprudence , United Kingdom/epidemiologySubject(s)
COVID-19/prevention & control , Communicable Disease Control/organization & administration , Professional Misconduct/legislation & jurisprudence , State Medicine/organization & administration , COVID-19/epidemiology , Communicable Disease Control/legislation & jurisprudence , Humans , Pandemics/prevention & control , State Medicine/legislation & jurisprudence , United Kingdom/epidemiologySubject(s)
COVID-19/therapy , Delivery of Health Care, Integrated/legislation & jurisprudence , Health Policy/legislation & jurisprudence , Health Services Accessibility/legislation & jurisprudence , Medical Oncology/legislation & jurisprudence , Neoplasms/therapy , State Medicine/legislation & jurisprudence , Waiting Lists , COVID-19/diagnosis , COVID-19/economics , Delivery of Health Care, Integrated/economics , Government Regulation , Health Care Costs , Health Policy/economics , Health Services Accessibility/economics , Humans , Medical Oncology/economics , Neoplasms/diagnosis , Neoplasms/economics , Policy Making , State Medicine/economics , United KingdomSubject(s)
COVID-19 Vaccines/therapeutic use , COVID-19/prevention & control , State Medicine/legislation & jurisprudence , Health Personnel/legislation & jurisprudence , Health Personnel/statistics & numerical data , Humans , State Medicine/organization & administration , State Medicine/statistics & numerical data , United KingdomSubject(s)
Government Agencies/organization & administration , Health Care Rationing/economics , Personal Protective Equipment/economics , State Medicine/organization & administration , COVID-19/economics , COVID-19/epidemiology , COVID-19/prevention & control , Contracts/economics , Contracts/legislation & jurisprudence , Government Agencies/economics , Government Agencies/legislation & jurisprudence , Health Care Rationing/legislation & jurisprudence , Humans , Pandemics/economics , Pandemics/prevention & control , State Medicine/economics , State Medicine/legislation & jurisprudence , United Kingdom/epidemiologySubject(s)
Accreditation/legislation & jurisprudence , COVID-19 Drug Treatment , Ethics, Pharmacy , Homeopathy/ethics , State Medicine/legislation & jurisprudence , Administration, Sublingual , Anticonvulsants/adverse effects , COVID-19/diagnosis , COVID-19/epidemiology , Communication , Female , Fentanyl/administration & dosage , Homeopathy/economics , Humans , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , State Medicine/organization & administration , Testosterone Congeners/adverse effects , Testosterone Congeners/supply & distribution , Testosterone Congeners/toxicity , United Kingdom/epidemiology , Vaccines/standards , Vaccines/therapeutic use , Valproic Acid/adverse effectsABSTRACT
INTRODUCTION: Hospital admissions from COVID-19 initially increased rapidly within the UK. National Health Service (NHS) field hospitals are part of a capacity building response built at great scale and speed to respond to the anticipated increased demand the NHS faces during this time. NHS Nightingale Hospital Birmingham (NHB) is modelled to treat mild to moderate (non-critical care) COVID-19 disease, to provide step-down capacity for patients in recovery, or for palliating patients in the dying phase of their disease in the Midlands. Opportunities and challenges presented for optimal medicines management (MM) during the development of the NHB are investigated, and a framework developed to support future NHS field hospitals of this model. METHODS: A team, comprised of an associate medical director, trust chief pharmacist and senior pharmacists iteratively developed a framework to convert the large non-hospital setting into a functioning NHS field hospital with standardised MM processes adjusted appropriately to cope with operational constraints in the pandemic situation. NHB has, because of its repurposing, both challenges and advantages affecting MM that influence development of the framework. Throughout implementation, a 7-week period between announcement and opening, there was continuous evaluation, external stakeholder validation and peer review. RESULTS: The PESTLE model, a mechanism of analysis to identify elements of a project environment (Political, Environmental, Social, Technological, Legal and Economic), was applied to identify influencing factors and support detailed project planning. Compliance with medicines legislation was at the forefront of all MM process development for the NHB field hospital. Internal factors were identified by the core MM team, resulting in a workforce, education & training and clinical pharmacy MM plan. DISCUSSION: MM processes are extensive and integral to NHS field hospitals. The presented framework of influencing factors may support future NHS field hospital development. It is pertinent to have a broad team working approach to any large-scale project such as outlined here, and suggest the identified factors be used as a core framework for development of any future MM processes in NHS field hospitals.
Subject(s)
COVID-19 , Hospital Administration/trends , Medication Therapy Management/organization & administration , Mobile Health Units/organization & administration , Pandemics , State Medicine/organization & administration , Health Facility Planning , Hospital Bed Capacity/statistics & numerical data , Humans , Medication Systems, Hospital , Medication Therapy Management/legislation & jurisprudence , Models, Organizational , Organizational Policy , Pharmacists , Pharmacy Service, Hospital , State Medicine/legislation & jurisprudence , United Kingdom , WorkforceSubject(s)
Change Management , Communicable Disease Control , Coronavirus Infections , Pandemics , Pneumonia, Viral , Betacoronavirus , COVID-19 , Communicable Disease Control/legislation & jurisprudence , Communicable Disease Control/organization & administration , Coronavirus Infections/epidemiology , Coronavirus Infections/prevention & control , England/epidemiology , Health Services Needs and Demand , Humans , Intersectoral Collaboration , Pandemics/prevention & control , Pneumonia, Viral/epidemiology , Pneumonia, Viral/prevention & control , Quality Improvement , SARS-CoV-2 , Social Work/standards , State Medicine/legislation & jurisprudence , State Medicine/standards , State Medicine/trendsABSTRACT
Richard Griffith, Senior Lecturer in Health Law at Swansea University, discusses the lawfulness of instructions to issue bulk do not attempt resuscitation orders during the COVID19 pandemic.
Subject(s)
Coronavirus Infections/epidemiology , Pandemics , Pneumonia, Viral/epidemiology , Resuscitation Orders/legislation & jurisprudence , COVID-19 , Humans , Legislation, Nursing , State Medicine/legislation & jurisprudence , United Kingdom/epidemiologyABSTRACT
John Tingle, Lecturer in Law, Birmingham Law School, University of Birmingham discusses the recently published Cumberlege report on medicines and medical devices safety.
Subject(s)
Annual Reports as Topic , Patient Safety , State Medicine/legislation & jurisprudence , COVID-19 , Coronavirus Infections/epidemiology , Humans , Pandemics , Pneumonia, Viral/epidemiology , United Kingdom/epidemiologyABSTRACT
In March 2020, the Government produced a document entitled "Responding to COVID-19: The Ethical Framework for Adult Social Care" ('The Ethical Framework'). In this article, we summarise the key features of the proposed ethical framework and subject it to critical analysis. We highlight three primary issues. First, the emphasis placed on autonomy as the primary ethical principle. We argue if ever there was a context in which autonomy should dominate the ethical analysis, this is not it. Second, we examine the interface between ethics and law which is largely overlooked in the document. Finally, we explore the surprising lack of attention paid to the concept of responsibility and communal obligations within the framework.
Subject(s)
Coronavirus Infections/therapy , Decision Making/ethics , Ethical Analysis , Ethics, Medical , Legislation, Medical/ethics , Personal Autonomy , Pneumonia, Viral/therapy , Social Responsibility , Adult , Betacoronavirus , COVID-19 , Coronavirus Infections/epidemiology , Ethical Theory , Humans , Pandemics , Pneumonia, Viral/epidemiology , SARS-CoV-2 , State Medicine/ethics , State Medicine/legislation & jurisprudence , United KingdomSubject(s)
Ethnicity/statistics & numerical data , Physical Examination/standards , State Medicine/legislation & jurisprudence , Humans , Male , Physical Examination/statistics & numerical data , Risk Factors , State Medicine/organization & administration , United Kingdom/epidemiology , United Kingdom/ethnology , Young AdultABSTRACT
John Tingle, Lecturer in Law, Birmingham Law School, University of Birmingham, discusses how the Courts may view clinical negligence claims brought by families who have lost loved ones during the pandemic.